Trial Profile
Phase I study of tocladesine in patients with colorectal carcinoma following therapy with 5-FU and irinotecan
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Aug 2013
Price :
$35
*
At a glance
- Drugs Tocladesine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Sep 2005 New trial record.